Losing the Forest for the Trees: The Complexities of Fibrinolysis Will Never Be Explained with One Variable Alone
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Coleman J, Moore E, Kelher M, Jones K, Cohen M, Banerjee A
. Elucidating the molecular mechanisms of fibrinolytic shutdown after severe injury: The role of thrombin-activatable fibrinolysis inhibitor. J Trauma Acute Care Surg. 2023; 94(6):857-862.
PMC: 10205661.
DOI: 10.1097/TA.0000000000003911.
View
2.
Cralley A, Moore E, Coleman J, Vigneshwar N, Bartley M, Kissau D
. Hemorrhagic shock and tissue injury provoke distinct components of trauma-induced coagulopathy in a swine model. Eur J Trauma Emerg Surg. 2022; 49(2):1079-1089.
PMC: 10802987.
DOI: 10.1007/s00068-022-02148-x.
View
3.
Anand K, Pallares I, Valnickova Z, Christensen T, Vendrell J, Wendt K
. The crystal structure of thrombin-activable fibrinolysis inhibitor (TAFI) provides the structural basis for its intrinsic activity and the short half-life of TAFIa. J Biol Chem. 2008; 283(43):29416-23.
PMC: 2662027.
DOI: 10.1074/jbc.M804003200.
View
4.
Kindell D, Keck R, Jankun J
. Comparison between the clot-protecting activity of a mutant plasminogen activator inhibitor-1 with a very long half-life and 6-aminocaproic acid. Exp Ther Med. 2015; 9(6):2339-2343.
PMC: 4473484.
DOI: 10.3892/etm.2015.2399.
View
5.
Nakae R, Murai Y, Wada T, Fujiki Y, Kanaya T, Takayama Y
. Hyperfibrinolysis and fibrinolysis shutdown in patients with traumatic brain injury. Sci Rep. 2022; 12(1):19107.
PMC: 9646769.
DOI: 10.1038/s41598-022-23912-4.
View